ANDROGEN SCIENCENAUKA O ANDROGENIMA

Medical testosterone and performance use: same receptor, different clinical meaningMedicinski testosteron i upotreba radi performansi: isti receptor, različito kliničko značenje

A molecule can have an established medical role while carrying a very different evidence and risk profile when used without an indication or at supraphysiological exposure.Molekul može imati utemeljenu medicinsku ulogu, a sasvim drugačiji profil dokaza i rizika kada se koristi bez indikacije ili pri suprafiziološkoj izloženosti.

Evidence baseBaza dokazaClinical guideline + observational evidenceKliničke smernice + opservacioni dokazi

Three points to retainTri ključne poruke

Testosterone therapy is intended for appropriately diagnosed hypogonadism, not simply low energy, ageing or a bodybuilding goal.Terapija testosteronom namenjena je odgovarajuće dijagnostikovanom hipogonadizmu, a ne samo manjku energije, starenju ili bodibilding cilju.

Performance use commonly changes exposure, combinations, treatment goals and acceptable risk; evidence from replacement therapy cannot be transferred intact.Upotreba radi performansi često menja izloženost, kombinacije, cilj i prihvatljiv rizik; dokazi iz nadoknadne terapije ne mogu se nekritički preneti.

Bodybuilding outcomes such as mass, strength or appearance do not demonstrate medical benefit or long-term safety.Bodibilding ishodi poput mase, snage ili izgleda ne dokazuju medicinsku korist niti dugoročnu bezbednost.

What makes use medicalŠta primenu čini medicinskom

Medical testosterone treatment begins with a clinical question: are compatible symptoms accompanied by consistently low serum testosterone caused by a defined disorder of the testes, pituitary or hypothalamus? The Endocrine Society guideline recommends diagnosis only when symptoms and unequivocally, consistently low concentrations occur together, with further evaluation of the cause.Medicinsko lečenje testosteronom počinje kliničkim pitanjem: da li su odgovarajući simptomi praćeni dosledno niskim serumskim testosteronom usled definisanog poremećaja testisa, hipofize ili hipotalamusa? Smernica Endocrine Society preporučuje dijagnozu samo kada se simptomi i jasno, dosledno niske koncentracije javljaju zajedno, uz dalju procenu uzroka.

The therapeutic goal is to treat a diagnosed condition using a regulated product, clinically selected exposure and follow-up. Benefits and risks belong to that specific indication, patient and formulation.Terapijski cilj je lečenje dijagnostikovanog stanja regulisanim proizvodom, klinički odabranom izloženošću i praćenjem. Koristi i rizici pripadaju toj konkretnoj indikaciji, pacijentu i formulaciji.

What changes in bodybuilding useŠta se menja u bodibilding primeni

Nonmedical use pursues outcomes such as hypertrophy, strength, recovery or preservation of lean mass. It may involve supraphysiological exposure, multiple androgens and additional performance or image-enhancing drugs. This changes both the biological exposure and the uncertainty around attribution when a benefit or adverse event occurs.Nemedicinska upotreba teži ishodima poput hipertrofije, snage, oporavka ili očuvanja nemasne mase. Može uključivati suprafiziološku izloženost, više androgena i dodatne supstance za performanse ili izgled. Time se menjaju i biološka izloženost i neizvesnost pripisivanja kada se pojavi korist ili neželjeni događaj.

The existence of a licensed testosterone medicine does not validate an unregulated vial, a different ester, a multi-drug stack or a nonmedical objective. Medical evidence should not be used as a safety halo for a materially different pattern of exposure.Postojanje registrovanog leka sa testosteronom ne potvrđuje neregulisanu bočicu, drugi estar, kombinaciju više supstanci niti nemedicinski cilj. Medicinski dokazi ne treba da služe kao oreol bezbednosti za suštinski drugačiji obrazac izloženosti.

What responsible coverage should sayŠta odgovorno izveštavanje treba da kaže

AEVANOVA will describe why compounds are used in medicine and bodybuilding, but will keep indication, evidence, exposure and outcome separate. Describing a practice is not endorsing it, and laboratory monitoring cannot convert nonmedical use into a proven safe protocol.AEVANOVA će opisivati zašto se jedinjenja koriste u medicini i bodibildingu, ali će odvajati indikaciju, dokaze, izloženost i ishod. Opisivanje prakse nije njeno odobravanje, a laboratorijsko praćenje ne može nemedicinsku upotrebu pretvoriti u dokazano bezbedan protokol.

Primary and authoritative sourcesPrimarni i autoritativni izvori

Educational boundaryEdukativna granica

Evidence is not an individual protocol.Dokazi nisu individualni protokol.

This article explains published evidence and observed use. It does not provide medical advice, a cycle, a dose, a recovery regimen or confirmation that any non-prescribed product is suitable for human use.Ovaj tekst objašnjava objavljene dokaze i opaženu upotrebu. Ne pruža medicinski savet, ciklus, dozu, režim oporavka niti potvrdu da je bilo koji nepropisani proizvod pogodan za primenu kod ljudi.